Thursday, November 14, 2024

Thursday, November 14, 2024

Latest News

FDA: Federal judge enters order of permanent injunction against New York company for distributing unapproved drugs

A federal judge has ordered two individuals doing business as Sundial Herbal Products to stop distributing unapproved new drugs and misbranded drugs until they comply with federal law.

FDA: Coronavirus (COVID-19) Update: FDA Publicly Shares Antibody Test Performance Data From Kits as Part of Validation Study

U.S. Food and Drug Administration publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent performance validation study effort with the National Institutes of Health’s (NIH) National Cancer Institute (NCI)

UNIVERSAL PACKAGING: Shifts Focus to COVID-19 Solutions by Providing FDA-Approved Face Masks

Leading Provider to National Pharmaceutical and Long-Term Care Industries Has 3-Ply Surgical and KN95 Masks In Stock, Ready to Ship Same Day.

NOVADOZ PHARMACEUTICALS: FDA Approvals of Oseltamivir and Dofetilide Continues the Company's Rise in the Generic Market

Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, located in Hyderabad India, recently received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide Capsules.

TRANSIT SCIENTIFIC: FDA Clears Innovative Angioplasty Scoring and Cutting Platform

New metal-alloy sheath converts angioplasty balloons into scoring and cutting systems

WELLDOC: Receives FDA Clearance for Long-Acting Insulin Support for Award-Winning Digital Health Solution BlueStar®

Marks 8th FDA clearance for BlueStar, the only reimbursable software as a medical device for diabetes that integrates with all of a patient's existing devices

ACCESS MEDICAL: Announces Ultra Sonic Speed Results for SARS-CoV-2 Antibodies that is 100% sensitive and has an EUA from the FDA

The New 10 minute Antibody Test from Access Medical Labs sets a new standard after the CDC announced antibody testing may be wrong 50% of the time

AAPS: Association of American Physicians & Surgeons (AAPS) Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine

The Association of American Physicians & Surgeons (AAPS) filed a lawsuit, AAPS v. FDA, against the Food and Drug Administration to end its arbitrary interference with the use of hydroxychloroquine (HCQ), which President Trump and other world leaders have taken as a prophylaxis against COVID-19.

CITIUS: Receives Positive FDA Feedback on Its Submitted Plan to Study Catheter Compatibility for Mino-Lok® Therapy

Compatibility plan includes testing representative samples of all commercially available CVCs and PIC

FDA: Coronavirus (COVID-19) Update: FDA Reissues Emergency Use Authorizations Revising Which Types of Respirators Can Be Decontaminated for Reuse

In response to public health and safety concerns about the appropriateness of decontaminating certain respirators, the agency is reissuing certain emergency use authorizations (EUAs) to specify which respirators are appropriate for decontamination.

LAMINATE MEDICAL TECHNOLOGIES: VasQ™ External Support Awarded Breakthrough Device Designation by the FDA

The FDA has designated Laminate Medical's VasQ™ External Support for the creation of arteriovenous fistulas (AVF) in hemodialysis patients as a Breakthrough Device.

FDA: Federal Government Announces New Pilot Program to Help Stop Illegal Availability of Unapproved Opioids Online

The U.S. Food and Drug Administration and the National Telecommunications and Information Administration (NTIA) are launching a 120-day pilot to help reduce the availability of unapproved opioids illegally offered for sale online.

MNA: FDA Reversal on COVID-19 Mask Decontamination Follows MNA Opposition, Demonstrates Urgent Need for Implementation of Frontline Nurse and Healthcare Professional Guidance

MNA nurses and healthcare professionals called for the halt of COVID-19 mask decontamination in April, finding lack of safety, efficacy evidence

THERMO FISHER: Extends NanoDrop One/OneC Spectrophotometer to FDA-Regulated Companies

New software can be used by pharma, biotech labs to comply with Title 21 CFR Part 11 data integrity regulations

FDA: Coronavirus (COVID-19) Update: FDA Authorizes First Next Generation Sequence Test for Diagnosing COVID-19

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next generation sequence technology.

CHROMACODE: FDA Issues Emergency Use Authorization for ChromaCode's High-Throughput HDPCR™ SARS-CoV-2 Real-Time PCR Assay

High-Definition PCR SARS-CoV-2 assay increases test throughput and reduces complexity of interpretation; ChromaCode customers enjoy inventory guarantee

FDA: Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord

Second FDA Approved Therapy for Neuromyelitis Optica Spectrum Disorder Offers Patients Additional Treatment Option

CHILDREN'S NATIONAL HOSPITAL: FDA Grant and Gift from Entrepreneur Provide $250K in Awards for Pediatric Medical Device Competition Focused on COVID-19 Innovations

Virtual competition staged by National Capital Consortium for Pediatric Device Innovation (NCC-PDI) now accepting applications for devices addressing COVID-19 needs

FDA Reporter